Caplin Point Laboratories fell 2.38% to Rs 2,497.25 after the company said that the USFDA conducted an unannounced inspection of its subsidiary Caplin Steriles' injectable and ophthalmic manufacturing facility at Gummidipoondi, Tamil Nadu.
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.